Conference Coverage (SPIRAT/NCDDG-HIV)
Cyclophilin: A Cellular Target for Anti-HIV Drugs
Published in Vaccine Weekly, July 21st, 1997
The protein, cyclophilin A, is known mainly because it binds the immunosuppressive drug cyclosporine. Non-immunosuppressive drugs that bind cyclophilin and inhibit HIV are already under development; the new findings show why they work and provide the basis for improvements.
"These studies suggest new ways of disrupting HIV-1 replication," said Jeremy Luban of Columbia University, New York, in an address to "New Opportunities for HIV Therapy - From Discovery to Clinical Proof-of-Concept," the 2nd Joint Conference of the National Institute of Allergy and Infectious Diseases...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1997-07-21)
More Articles from Vaccine Weekly
- Conference Coverage (SPIRAT/NCDDG-HIV)
Trials of HIV and HBV CTL Vaccines Underway in HIV+ Patients - Conference Coverage (SPIRAT/NCDDG-HIV)
HIV CTL Escape Mechanism "Bad News" For AIDS Vaccines - Bacterial Vaccines
Vaccination Could Increase Carriage of New Bacterial Serotypes - Cancer Gene Therapy
Combination Immunogene Therapy Effective In Glioblastoma Model - HIV Vaccines
Potential Vaccine Development Announced for Worldwide Use - Immunization
Study Injects New Interest In How Vaccines Work - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
